Lauren Nelson

Head, Market Access & Trade at Tris Pharma

Speaker

Lauren leads Market Access, Trade and Patient Access at Tris Pharma across the company’s specialty-lite portfolio in ADHD. Her team also holds responsibility for Access and Trade strategies for Tris’ pipeline products, where they expect 5 indication and product launches over the next 5 years. With more than 20 years in the pharmaceutical industry, her experience spans the full access spectrum — from open retail through ultra-rare disease and gene therapy, across both the pharmacy and medical benefit. She has held roles at Takeda, Biogen, Sanofi Genzyme, and Albireo, among others and has built multiple Access functions from the ground up at pre-commercial companies preparing for commercialization.